Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06418152 · ClinicalTrials.gov registry record · NA
Dual-task Augmented Reality for PD DBS
A NA study, sponsored by Jay Alberts.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT06418152: Completed NA study, sponsored by Jay Alberts.
NCT06418152 is a NA study that has completed, run by Jay Alberts. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06418152, a NA study, has completed, sponsored by Jay Alberts.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The goal of this project is to evaluate the safety and preliminary effectiveness of utilizing a digital therapeutic, Dual-task Augmented Reality Treatment (DART) protocol, for the treatment of postural instability and gait dysfunction (PIGD) in individuals with PD with a previously implanted deep brain stimulator (DBS).
Primary Outcome
Movement Disorder Society Unified Parkinson's Disease Rating Scale Part III: Motor Examination score, measured off medication. Range of scores is 0 to 132, with lower score indicating better motor function. Change in MDS-UPDRS III score from baseline through completion.
Interventions
- BEHAVIORAL Multi-modal treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2024-05-21 |
| Est. Completion | 2025-01-30 |
| Phase | NA |
What the finished NCT06418152 record still lists
NCT06418152 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Multi-modal treatment is the first listed.
NCT06418152 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06418152 about?
NCT06418152 is a clinical study titled "Dual-task Augmented Reality for PD DBS". The goal of this project is to evaluate the safety and preliminary effectiveness of utilizing a digital therapeutic, Dual-task Augmented Reality Treatment (DART) protocol, for the treatment of postural instability and gait dysfunction (PIGD) in individuals with PD with a previously implanted deep br...
What is the current status of trial NCT06418152?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2024-05-21. Estimated completion is 2025-01-30.
What interventions are being tested in trial NCT06418152?
The interventions under investigation include: Multi-modal treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT06418152?
This trial is sponsored by Jay Alberts, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06418152's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI